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ABSTRACT
Glioblastoma Multiforme (GBM) is the highest-grade glioma and the most malignant 
form of astrocytoma (Brat and Mapstone, 2003; Hjelmeland and others). Diagnosis of GBM 
carries a prognosis of less than 14 months after diagnosis, despite surgical intervention, 
radiation, and chemotherapy (Hjelmeland and others). Unfortunately, the prognosis of GBM 
has remained unchanged over the last thirty years, even with abundant resources devoted to 
research (Barres, 2008). GBM tumors have a low intracellular pH that results in increased 
levels of proliferation and decreased levels of apoptosis. As a result, astrocytes, the cell type 
responsible for GBM, have been cultured and evaluated to understand the behavior of GBM 
astrocytes.
Previous data shows that astrocytes cultured at pH 7.0 for several days will have 
higher cell numbers than those grown at the physiological pH 7.4 (Guercio, 2012). In these 
studies cell numbers were evaluated using manual counting to compare differences between 
culture conditions. A more automated approach that can evaluate multiple parameters on the 
same set of cells would allow for better understanding of the changes in proliferation and 
apoptosis in cultured cells. This would allow for more rapid turnover and consistent 
evaluation from culture to culture. Here we evaluated whether Promega’s ApoTox-Glo™ 
Triplex assay would produce reliable and repeatable results using cultured astrocytes. This 
assay evaluates levels of viability, cytotoxicity, and apoptosis in same set of cells.
Adult and Embryonic day 18 (E l8) cells were harvested and cultured at either pH 7.0 
or pH 7.4 for several days. Following the culture period, viability, cytotoxicity, and apoptosis 
levels were evaluated using the ApoTox-Glo™ Triplex Assay. Three different runs were 
completed and the results between runs varied, yet the results within runs were very 
consistent.
Viability or the number of live cells varied for each run of the assay with no 
consistent trends seen. Cytotoxicity or number of dead cells also varied between runs with 
El 8 cells, but adult cells showed a consistent trend of increased cytotoxicity at pH 7.4. 
Similar to viability, apoptosis levels showed varied results but with high variability from run 
to run and again, no consistent trends seen.
Although the results varied from run to run, results within each run were consistent. 
This suggests that this assay can be used with astrocytes and that further evaluation with 
different toxins that change viability, cytotoxicity, and apoptosis should be used to test the 
sensitivity of the kit. In addition to further work up with astrocytes, GBM cell lines should be 
evaluated to determine if this assay could be used to evaluate changes in viability, 
cytotoxicity, and apoptosis with novel treatments.
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INTRODUCTION
In 1858, a scientist by the name of Rudolf Virchow wrote, “Hitherto, gentleman, in 
considering the nervous system, 1 have only spoken of the really nervous parts of it. But if we 
would study the nervous system in its real relations in the body, it is extremely important to 
have a knowledge of that substance also which lies between the proper nervous parts, holds 
them together and gives the whole its form in a greater or less degree” (Kettenmann and 
Verkhratsky, 2008; Virchow, 1871) . Virchow realized the need to understand the cells in the 
central nervous system (CNS) that were not neurons. That substance Virchow referred to is 
known as glial cells. Initially thought to be filler, the discovery of glia has given way to 
extensive research, research that is not yet complete.
Since the discovery of glia, it has been found that they come in many varieties, serve 
many functions within the CNS, and outnumber neurons by 3:l(Purves, 2012). Within the 
CNS, glia provide a scaffolding for neurons, guide neuronal migration, participate in synaptic 
transmission, and support electrical signals (Kettenmann and Verkhratsky, 2008; Ndubaku 
and de Bellard, 2008; Purves, 2012). Glia come in three varieties in the CNS; astrocytes, 
oligodendrocytes, and microglia, each of which serve different specialized functions.
Astrocytes are found only in the CNS and have a star-like appearance due to 
processes that protrude radially around the cell body. The function of astrocytes is to remove 
neurotransmitters and maintain ion concentrations at the synaptic cleft to support normal 
neuronal function. Astrocytes are one of few cells in the body that retain the characteristics of
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stem cells which gives them the ability to generate all classes of glia found in nervous tissue
(Jessen, 2004; Kettenmann and Verkhratsky, 2008; Ndubaku and de Bellard, 2008; Purves,
2012).
Oligodendrocytes, which are also restricted to the CNS, are responsible for 
synthesizing myelin and ensheathing the axons of neurons. Myelin helps increase the rate at 
which an electrical signal is propagated along the axon. Cells similar in function to 
oligodendrocytes exist in the peripheral nervous system. These cells are known as Schwann 
cells and serve the same purpose for peripheral neurons (Jessen, 2004; Ndubaku and de 
Bellard, 2008; Purves, 2012; Travis, 1994).
Lastly, microglia are the macrophages of the CNS. Microglia surveil the CNS and 
clean up any debris or waste products at sites of injury or disease (Jessen, 2004; Purves, 
2012; Travis, 1994). Together astrocytes, oligodendrocytes, and microglia provide support 
for the central nervous system and help maintain a balanced environment for neurons.
All three types of glia work hard to maintain the CNS and facilitate optimal neuronal 
function. Therefore, when there is an insult to the CNS all classes of glia may become 
activated. Insults to the CNS include but are not limited to ischemia, hypoxia, and trauma, all 
of which have the ability to activate glia. If activated, oligodendrocytes will try to 
remyelinate any damaged axons, microglia will start to phagocytize and clean up any debris 
at the site, and astrocytes will begin walling off the area to minimize secondary injury (Fitch 
and Silver, 2008; Jessen, 2004). During the process of “walling o ff’, activated astrocytes can
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form a dense structure called a glial scar (Fitch and Silver, 2008; Jessen, 2004). Glial scars 
are mixtures of astrocytes and connective tissue that serve as a space filler and act as a 
physical barrier to block regeneration/reconnection of affected neurons. This results in a 
permanent termination of communication between neurons. Unlike the CNS, neuronal injury 
in the peripheral nervous system can be repaired depending on the extent of damage. Some 
researchers believe that an insult to the CNS followed by activation of glia can lead to 
malignant tumors or “gliomas”, however this theory is not yet validated (Salvati and others, 
2004).
Gliomas are tumors that arise from glial cells. Gliomas can arise from any of the glia 
described previously and the responsible cell type will be identified within the name of the 
tumor. The most malignant type of glioma is glioblastoma multiforme (GBM), a grade IV 
astrocytoma (Parsons and others, 2008). GBM tumors arise from astrocytes and are very 
infiltrative. Despite aggressive treatment, GBM has maintained the same prognosis for over 
30 years.
When patients are diagnosed with GBM, the standard of care is resection, followed 
by radiation and chemotherapy. Even with this aggressive treatment the median survival time 
is 15 months following diagnosis (Parsons and others, 2008). Resistance to apoptosis, high 
angiogenicity, and/or most importantly very active proliferation all contribute to this 
prognosis (Sarafian and others, 2009). A combination of active proliferation followed by 
resistance to apoptosis can only lead to one thing a large, rapidly growing, infiltrative tumor.
Cell death can occur in one of two ways: necrosis or apoptosis. Necrosis is typically a 
result of trauma or injury, involves contiguous tissue, occurs rapidly, and causes 
inflammation. Apoptosis is programmed cell death, a process the body uses to remove un­
needed or old, worn-out cells. Apoptosis is usually only individual cells and is a carefully 
orchestrated series of events that result in cellular fragments that are cleared by the immune 
system with little to no inflammation (Steinbach and Weller, 2004; Takagi and others, 2003). 
Apoptosis may be triggered by multiple intrinsic or extrinsic signals and may last from hours 
to days depending on the cell type or types involved.
Within the CNS, cells have varying resistance to apoptosis. Neurons are the most 
susceptible, followed by oligodendrocytes, astrocytes, endothelial cells, and the most 
resistant cells being microglia (Sarafian and others, 2009). Some of the CNS signals for 
initiation of apoptosis in glia include an elevation in cytosolic calcium, oxidative stress, the 
presence of nitric oxide, mitochondrial disruption, endoplasmic reticulum stress, and protease 
activation (Takagi and others, 2003; Takuma and others, 2004). Of interest here is protease 
activation, specifically caspase activation.
Caspases (cysteine aspartate-specific proteases) are proteases that cleave an 
intracellular peptide at the position next to the aspartic acid residue (Creagh and Martin,
2001; Dressier and others, 2007; Takagi and others, 2003). Fourteen caspases have been 
identified in the apoptotic cascade (Figure 1), however there is still very little known about 
most of them (Creagh and Martin, 2001). Caspases are identified by numbers 1-14 and 
divided into two groups; initiators or effectors. Initiator caspases are the proteases
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responsible for the start or “initiation” of the apoptosis cascade, these include caspase-2, -8, - 
9 and -10 (Creagh and Martin, 2001; Takagi and others, 2003). Effector caspases are the 
proteases responsible for executing the demolition of the cell during apoptosis and include 
caspase-3, -6, and -7 (Creagh and Martin, 2001; Takagi and others, 2003).
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Figure 1 : Picture of complexity of caspase cascade (Garcia-Martin and others, 2001)
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Caspases trigger cellular demolition by promoting the release of cytochrome c from 
the mitochondria and cleaving integral proteins within the cytoplasm and nucleus (Creagh 
and Martin, 2001). GBM is known to possess a resistance to apoptosis, but the mechanism is 
not fully understood. It is speculated that in GBM there are mutations in various parts of the 
apoptotic pathway that prevent activation of the cascade or halt it at certain levels, however it 
has not been proven (Steinbach and Weller, 2004; Ziegler and others, 2008).
The opposite of apoptosis is proliferation, or the reproduction/expansion of cells. 
Proliferation can occur independently or coupled with apoptosis to repair and/or replace 
cells. Like apoptosis, proliferation is under strict control and in most cases functions 
normally. Innate surveillance mechanisms will monitor and rid the body of abnormal cells, 
control the rate of proliferation, and monitor cell quality and quantity to prevent the 
formation of tumors. Unfortunately, when there is a malfunction in the control of 
proliferation, a cancerous tumor can result. In general, most cells in the adult brain do not 
proliferate or divide after development, but when triggered via trauma or insult, astrocytes 
can activate their stem cell properties and proliferate or generate all glia cell types in the CNS 
(Guizzetti and others, 2011). In the case of GBM, proliferation is up regulated, which 
contributes to its infiltrative properties (Sarafian and others, 2009).
Proliferation in astrocytes follows the same steps as normal cellular proliferation. 
Cells will first start in Gapo, followed by Gapi, Gap2 , and finally enter mitosis, resulting in 
the generation of two daughter cells (Guizzetti and others, 2011). Usually cells require a 
signal or stimulus to proliferate, but GBM has the ability to enter into the cell cycle without
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mitogenic stimulation (Kelly and others, 2009). Uncontrolled proliferation results in a rapid, 
exponential growth of cells.
Research has shown that a pH lower than the physiological pH of 7.4 increases 
proliferation of astrocytes in culture through the interaction of acid-sensing ion channels 
(ASIC) with voltage-dependent large-conductance calcium-activated potassium channels 
(BK) (Petroff and others, 2012). ASICs block BK channels at the physiological pH of 7.4 and 
in the presence of a slightly more acidic pH of 7.0 a conformational change occurs and 
results in relief of this inhibition (Petroff and others, 2012). There are many subtypes of 
ASICs, with ASIC la  being the channel found to interact with and inhibit BK channels 
(Petroff and others, 2012). BK channels are present in both normal and glioma cells and it 
has been found that their expression is positively correlated with the grade of glioma (Basrai 
and others, 2002; Berdiev and others, 2003; Liu and others, 2002; Ransom and Sontheimer, 
2001). Targeting ASIC, BK channels or their interaction site may serve as novel method to 
treat GBM once the mechanisms are fully understood.
In-vitro assays exist that can evaluate multiple parameters like apoptosis and 
proliferation in the same set of cells, but the use of astrocytes in these assays has not been 
published. Here we evaluated whether Promega’s ApoTox-Glo™ triplex assay can be used to 
produce reliable and reproducible results using cultured astrocytes. This colorimetric assay 
measures viability, cytotoxicity, and apoptosis in the same set of cells using fluorescence and 
luminescence. In this assay, viability represents the number of live or “viable” cells; 
cytotoxicity represents the number of dead or “non-viable” cells; and apoptosis represents the
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number of cells that are currently undergoing apoptosis. If successful, effects of different 
treatments on GBM cell lines in culture can be evaluated using this assay.
In order to assess the accuracy of this assay we used cultured adult and embryonic rat 
astrocytes, grown at either pH 7.0 or 7.4. After several days in culture, cells were evaluated 
for viability, cytotoxicity, and apoptotic activity using the ApoTox-Glo™ assay and results 
were analyzed for reliability.
MATERIALS AND METHODS
Merck Research Laboratories in Kenilworth New Jersey provided CD rats from 
Charles River Laboratories. All procedures using these rats were performed with permission, 
onsite and within established animal procedural statement guidelines approved by Merck’s 
International Animal Care and Use Committee (IACUC).
Adult Astrocyte Culture
CD Rats, 16 weeks or older were decapitated using approved methods. Using sharp, 
sterile scissors, the skin along the midline of the scalp was cut and the skull exposed. Next, 
using sterile forceps, membranes on the skull were removed. The skull was then cut along the 
midline using nail nippers and carefully pried off to reveal the brain. The brain was then 
rinsed with chilled Hanks Balanced Salt Solution without calcium and magnesium (HBSS), 
and carefully lifted out of the skull using the spoon end of a sterilized weighing spatula.
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Next, the brain was placed into chilled Hibernate AB (BrainBits® -HAB 500) and 
transported back to the culture laboratory.
In a sterile tissue culture hood, the brain was removed from the Hibernate AB, and 
placed on ice in a culture dish filled with clean Hibernate AB. Next, using sterile forceps, the 
meninges were removed from the cortex. With a sterile disposable scalpel, thin slices of the 
cortex were made at a 45° angle to the midline of the brain, avoiding the inner white matter. 
Slices were then placed into another clean culture dish on ice with Hibernate AB, and then 
carefully minced into smaller pieces using a new sterile sharp scissor. Minced pieces were 
then aspirated using a sterile Pasteur pipet and placed into a cell dissociation solution. The 
cell dissociation solution contained 3mL of Hibernate A without calcium (BrainBits® -HA- 
Ca) and 6mg papain (BrainBits® -PAP). The cell dissociation solution was prepared 
according to the BrainBits® papain protocol. Adult tissue was incubated in the dissociation 
solution for 30 minutes at 37°C and 5% CO2 and gently swirled every 5 minutes.
After 30 minutes, tissue was removed from the papain using a new sterile Pasteur 
pipet and placed into 3mL of Hibernate AB. Tissue was then triturated with a silanized fire 
polished pipette (BrainBits® -FPP) from BrainBits® for one minute to mechanically 
dissociate cells. Undispersed cells were allowed to settle for one minute, and then 
supernatant was transferred off using a new sterile Pasteur pipet into an empty 15mL conical 
tube, and centrifuged at 1 lOOrpm for one minute. The supernatant was then removed and 
discarded. Cells were re-suspended in lOmL of NbAstro (BrainBits® -NbAstro) and the 
mixture was then passed through a 40uM cell strainer. After filtration cells were again
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centrifuged at 1700rpm for 5 minutes, supernatant was removed and discarded, and cells 
were then re-suspended in lmL of NbAstro for counting.
Cells were counted using a hemacytometer then plated at a density of 7500 cells/cm2 
into BD BioCoat™ Poly-D-Lysine coated T25 flasks (#354536). Cultures were 
supplemented with 0.5% Gentamicin (Gibco# 15750-060) to prevent bacterial contamination.
After 24 hours in culture, cells were washed with NbAstro and the media changed to 
remove floating debris. Debris in culture were from contamination of other cell types due to 
the inability to completely clean the adult rat cortices during harvesting. An example of 
debris in the culture is seen in figure 2A; figure 2B shows the same culture after 11 days.
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Figure 2: A: Adult Cells pH 7.4, 5 days in culture. Note the debris in the flask that surrounds the cells. B: 
Adult cells, pH 7.4, 11 days in culture. Note how clear the culture is.
Embryonic Astrocyte Culture
Embryonic day 18 (El 8) rat cortices were purchased from BrainBits® and dissociated 
following BrainBits’® Primary Astroglial Protocol. Cells were then plated in the same type
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of plate and at the same density as adult cells. The culture protocol for the El 8 cells was 
similar to that used for adult cells, except the incubation with papain is ten minutes and cells 
are not run through a strainer since embryonic tissue is still mainly undifferentiated.
Culture Conditions
Both embryonic and adult cells were incubated in either pH 7.4 (37°C and 5% CO2 ) 
or pH 7.0 (37°C and 10% CO2 ) until 90% confluent. Confluency was achieved 10-14 days 
post plating. Media was changed every three to four days in all cultures to provide ample 
nutrients to the astrocytes.
Once cells were 90% confluent they were harvested using 0.05% Trypsin-EDTA 
(Life Technologies™ 25300-054). Adult and embryonic cells were incubated with trypsin for 
30 minutes to loosen their attachment to the flask. Cells were then aspirated with a 
serological pipette and placed into a 15mL conical tube. Cells were then centrifuged at 
1 lOOrpm for one minute then re-suspended in lmL NbAstro and counted.
ApoTox-Glo™ Triplex Assay
BD BioCoat® Poly-D-Lysine 96-well plates with black sides and clear bottoms were
used to run the ApoTox-Glo™ Triplex Assay. Cells were trypsinized and removed from their 
culture flasks and counted, then diluted to 24,000 cells/mL and lOOuL of each sample was 
added to each well. Viability and Cytotoxicity reagents from the ApoTox-Glo™ Triplex
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Assay were prepared according to manufacturer instructions then added to 96-well plate and 
the plate incubated at 37°C and 5% CO2 for 1.5 hours. After incubation, the plate was 
analyzed for fluorescence as defined in the protocol using a Gemini XPS plate reader from 
Molecular Devices.
The caspase reagents were then added to the plate and the plate was incubated at 
room temperature for an additional 1.5 hours. Luminescence was then measured.
Treat ceils with 
compound ot interest.
Add Viability,Cytotoxicity Reagent.
Measure lluorescertce at 
two wavelength sets 
(celi vuibilrty and cytotoxicity)
Add Caspase-Glo* 3/7 Reagent.
Measure luminescence 
(apoptosis).
Figure 3: ApoTox-Glo assay overview.
The ApoTox-Glo™ Triplex Assay was run three times on three different batches of 
cells. The first run of this assay only included El 8 cells that were in culture for 19 days. The 
adult cells that were co-cultured with El 8 cells acquired mold contamination and were 
discarded and not used. Twenty replicates per condition were plated to provide a robust
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sample for each group. The second run of the assay was on adult and El 8 cells at both pHs 
after 9 days in culture to evaluate the differences between time in culture. The third and final 
run was on adult and El 8 cells at both pHs that were in culture for 15 days. Cells were 
evaluated to determine if results are repeatable from assay to assay.
STATISTICS
Fluorescence and luminescence results were analyzed using a modified Excel sheet 
for ApoTox-Glo™ Triplex Assay from Promega’s website. Results shown have the 
fluorescence/luminescence of the media subtracted out.
Graphs and standard error of the mean (SEM) were generated within GraphPad Prism 
5. Statistics were determined using a t-test in Excel for the first run (2 groups). Runs two and 
three were analyzed using a 1-way ANOVA with a Bonferroni post-test among all pairwise 
comparisons in Prism (4 groups).
RESULTS
Results from the first run are shown in figure 4. Cells were counted prior to plating
and data is shown. This run analyzed E l8 cells only. Viability and cytotoxicity readouts 
contained very little variability as shown by small error bars (SEM). Results showed that
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cells grown at pH 7.0 grew faster than those at pH 7.4 did. There were no statistically 
significant differences between the two pHs for viability. However, cytotoxicity and 
apoptosis showed significant differences between the two pHs. Cytotoxicity showed a 
statistically significant difference between pHs with pH 7.4 having an increased number of 
dead cells per well. Apoptosis results showed a statistically significant difference that 
suggests wells at a pH of 7.4 contains more cells that are undergoing apoptosis.
E18 pH 7.0 E18 pH 7.4
Cytotoxicity
E18 pH 7.0 E18 pH 7.4
Unlike superscript represents p< 0.05
B
Viability
of
Embryonic Astrocytes
(After 19 days in Culture)
^ ---—---- 1----
E18 pH 7.0 E18 pH 7.4
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Apoptotic Activity
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Figure 4:Astrocytes were grown in culture for 19 days, then trypsinized and placed into 96-Well plates and 
assessed for Viability, Cytotoxicity and Apoptosis using Promega ApoTox-Glo™ Triplex Assay. This data 
suggests there are no significant differences in the number of viable cells; at pH 7.0 there are less cells that 
are currently dead and the caspase/apoptotic activity is also lower. This data supports previous data in 
suggesting the a more acidic environment inhibits apoptotic activity and decreases cell death. Proliferation 
is not analyzed here but may be a contributor to the survival of cells. A: Cell count using hemacytometer, 
showing that more cells grow at pH 7.0 B:Shows viability of embryonic cells, with no significant 
differences in viable/live cells between the two pH. C: Shows the cytotoxicity of embryonic cells, pH 7.0 
shows a larger reduction in dead cells than that of pH 7.4. D: Shows the apoptotic activity of embryonic 
cells, cells grown at pH 7.0 show less apoptotic activity than cells grown at pH 7.4.
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Results of the second run are shown in figure 5. This run included adult and El 8 cells 
grown at both pHs after 9 days in culture. Cell count again showed at pH 7.0, adult and E l8 
cells grew faster than when grown at pH 7.4. Variability was again small within the groups. 
There were significant differences across all pairwise comparisons for viability and 
cytotoxicity. However, apoptotic activity showed no significant differences. The results of 
this run were not similar to the first run; however, within each condition the signals were 
consistent which suggests that culture period has effects on all three parameters.
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Figure 5:Astrocytes were grown in culture for 9 days, then trypsinized and placed into 96-Well plates and 
assessed for Viability, Cytotoxicity and Apoptosis using Promega ApoTox-Glo™ Triplex Assay. This data 
suggests there are significant differences in viability and cytotoxicity between all pairwise comparisons; and 
the caspase/apoptotic activity is also lower in adult cells compared to embryonic at pH 7.0, and there 
appears to be no difference when comparing embryonic cells at pH 7.4 to adult cells at both pH as well as 
comparing pH within adult cells. This data supports previous data in suggesting the a more acidic 
environment inhibits apoptotic activity and decreases cell death. In theses graphs different superscripts 
representing a p<0.05 and similar letters showing no significant differences, using 1-way ANOVA with a 
Bonferroni post test with all pairwise comparisons. A:Shows cell count using hemacytometer, confirming 
that at pH7.0 astrocytes grow faster B:Shows viability of all groups of cells to be significantly different with 
respect to one another. C: Shows the cytotoxicity of all groups to be significantly different from one another.
D: Shows no significant differences in apoptotic activity
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Results of the third run are shown in figure 6. Adult and El 8 cells at both pH were 
analyzed after 14 days in culture to provide a comparison to the first run. Cell counts again 
showed that cells grown at pH grew faster than those grown at pH 7.4 did. Variability was 
again minimal. Significant differences in viability were seen in all pairwise comparisons, 
except among adult cells. There were statistically significant differences between all pairwise 
comparisons in cytotoxicity. Apoptotic activity has no significant differences. Results for 
El 8 cells showed similar trends in cytotoxicity and apoptosis when compared to run one. 
Results in adult cells showed similar trends in cytotoxicity only when compared to run two.
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Figure 6:Astrocytes were grown in culture for 14 days, then trypsinized and placed into 96-Well plates and 
assessed for Viability, Cytotoxicity and Apoptosis using Promega ApoTox-Glo™ Triplex Assay. This data is 
similar to the first run of this assay with cells that were 19 days in culture. A:Shows cell count using 
hemacytometer, confirming that at pH7.0 astrocytes grow faster B:Viability is significantly different between 
all pairwise comparisons, except when comparing between pHs in adult cells. C: Cytotoxicity is significantly 
different among all pairwise comparisons. D: There appears to be no significant difference in apoptotic
activity.
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DISCUSSION
The most challenging part was establishing a harvesting protocol for adult astrocytes. 
This was overcome and adult cultures behaved similar to El 8 cultures. Similar to previous 
data generated in our lab, differences in growth rates of astrocytes were seen when 
comparing between pHs. Astrocytes maintained at a pH 7.0 grew faster than those 
maintained at pH 7.4 did (Guercio, 2012). Adult astrocytes appeared to be smaller when 
compared to embryonic astrocytes. Culture conditions were similar to previous experiments 
in our laboratory, except the cells were in culture for almost two weeks before 90% 
confluency was achieved.
Viability was measured using a substrate that measures live-cell protease activity, 
GF-AFC (glycyl-phenylalanyl-aminofluorocoumarin). This substrate can only enter intact, 
viable cells and is cleaved by live-cell protease activity within the cell, resulting in a 
fluorescent signal. Each well contained the same concentration of cells, therefore it would be 
expected that the viability signal would not be significantly different between groups and was 
seen in the first run of the assay. In the second run adult and El 8 cells at pH 7.0 had 
significant differences from those at pH 7.4. The third run showed that E l8 cells had 
significant differences but adults did not.
Typically, the ApoTox-Glo™ Triplex Assay is run on cells in the same plate they 
grew in. Unfortunately, in this situation that was not possible to do this because cells needed 
to be in different incubators. To overcome this challenge, after their culture period cells were
25
cells were trypsinized and removed from their original flasks, diluted and plated so that they 
were all at the same density. Due to the dilution, evaluations of changes in viability using the 
ApoTox-Glo™ Triplex Assay are not reliable in this situation. However, it should be noted 
that the signals generated among wells in each group were consistent with little variability. 
This means that the viability readout could be used on cells that were not diluted. Differences 
seen here in viability are most likely due to effects of reagents from the ApoTox-Glo™ 
Triplex Assay on the cultured cells.
A second substrate, bis-AAF-Rl 10 (bis-alanylalanyl-phenylalanyl-rhodamine-110) is 
cell-impermeant and used to evaluate cytotoxicity in wells by measuring dead cell protease 
activity in the extracellular fluid. Similar to the viability reagent, a fluorescent signal 
proportional to the number of dead-cells is generated. El 8 cells in runs one and three had 
similar results, showing that more cells are dead at pH 7.4 than pH 7.0. E l8 cells in the 
second run were in culture for less time than cells in runs one and three and showed more 
dead cells at pH 7.0 than pH 7.4. This suggests that El 8 cells may be more fragile earlier in 
culture and culture period can cause a change in cytotoxicity regardless of pH. Adult cells 
were at different days in culture and results were still duplicated between the two runs, 
suggesting that culture period has no effect on adult cells. Results for adult astrocyte 
cytotoxicity showed that at pH 7.0 there are less dead cells than at pH 7.4. This data and the 
data from embryonic cells in runs one and three show that at a lower pH less cells die.
Evaluation of cytotoxicity will be valuable when examining the effects of compounds 
on cultured cells. Since the results were consistent among adult and embryonic cells at
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similar days in culture, this assay is reliable for a cytotoxicity endpoint. Evaluation of this 
assay using a GBM cell line should be considered to investigate responses of the cells to 
novel therapies for treatment of GBM.
Apoptotic activity in the ApoTox-Glo™ Triplex Assay is analyzed by using a 
caspase-3/7 substrate. The substrate induces cell lysis, releasing any active caspases into the 
surrounding media. Active caspase-3/7 will cleave the substrate and generate a luminescent 
signal that is proportional to the amount of activity. Like cytotoxic activity, runs one and 
three have similar results for El 8 and opposite results in run two. Adult cells did not show 
any significant differences among pHs in either run. Apoptosis results were repeatable when 
culture period was the same; further supporting that culture period has an effect. Again, these 
results support that this assay can be used with astrocytes.
Conclusions
Astrocytes evaluated using the ApoTox-Glo™ Triplex Assay may not have produced 
consistent results from run to run, but they did produce consistent fluorescence and 
luminescence signals within each subset of cells. This suggests that the variability may not 
arise from the assay itself but from actual changes in viability, cytotoxicity, and apoptosis 
within the astrocyte cultures. Differences may also arise from the sensitivity of cells to the 
reagents used, combined with an additional incubation period different from their original 
culture conditions. Since cells were grown in two different incubators, they were in 
suspension and not adhered to the 96-well plate when analyzed using the assay, which may 
contribute to the sensitivity of the cells and may cause variations in each run. Evaluation of
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cells in an adherent culture with different toxins or compounds known to affect viability, 
cytotoxicity, and apoptosis may provide results that are more consistent from run to run and 
this evaluation should be considered in the future. An adherent culture would allow changes 
in viability to be assessed since cells would grow at different rates and not be diluted and 
normalized between wells. Here cells were plated in the 96-well plate at the same 
concentration in each well after determining viable cell numbers; this may have limited the 
resolution of the viability endpoint. It should be noted that the effects of pH on cell growth 
were consistent with previous data, showing that at a slightly more acidic pH, cells grow 
faster.
Overall, the ApoTox-Glo™ Triplex Assay is a straightforward, easy to use assay that 
appears to provide results with little variability within each run of the assay. In this study, 
cells did not receive treatments that changed viability, cytotoxicity, or apoptosis; therefore, 
only baseline levels of these endpoints in different culture conditions were evaluated. This 
may have contributed to variability in results from run to run and reduced the magnitude of 
changes observed in all endpoints. These results are promising and provide enough support to 
confirm that consistent signals are generated and changes can be evaluated using cultured 
astrocytes. In the future, this assay can be used to understand the effects of treatments on 
astrocyte viability, cytotoxicity, and apoptosis and ultimately should be used with GBM 
astrocytes to evaluate novel treatment for GBM.
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